Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Acute Myeloid Leukemia”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableStudy completedNCT02662933
What this trial is testing

Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)

Who this might be right for
ACUTE MYELOGENOUS LEUKEMIA
Wake Forest University Health Sciences 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361
What this trial is testing

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
University of Southern California 33
Large-scale testing (Phase 3)Study completedNCT00480064
What this trial is testing

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 360
Testing effectiveness (Phase 2)Looking for participantsNCT06394011
What this trial is testing

Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

Who this might be right for
Intermediate Risk Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 60
Not applicableAvailableNCT06915766
What this trial is testing

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Who this might be right for
Systemic Mastocytoses, IndolentSystemic Mastocytoses, Aggressive
Cogent Biosciences, Inc.
Post-approval studies (Phase 4)Study completedNCT00180102
What this trial is testing

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 600
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Looking for participantsNCT05260528
What this trial is testing

CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice 210
Testing effectiveness (Phase 2)Study completedNCT01261312
What this trial is testing

SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
MDSCMMLAML
Astex Pharmaceuticals, Inc. 414
Testing effectiveness (Phase 2)Study completedNCT03338348
What this trial is testing

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
University of Ulm 9
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Large-scale testing (Phase 3)Study completedNCT02085408
What this trial is testing

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
ECOG-ACRIN Cancer Research Group 727
Large-scale testing (Phase 3)Looking for participantsNCT04168502
What this trial is testing

Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 414
Testing effectiveness (Phase 2)UnknownNCT00838240
What this trial is testing

Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 114
Large-scale testing (Phase 3)Study completedNCT02671708
What this trial is testing

IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT

Who this might be right for
Autologous Hematopoietic Stem Cell TransplantationAcute Myeloid LeukemiaConditioning
Nanfang Hospital, Southern Medical University 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT05599360
What this trial is testing

Vyxeos for Induction of Low- or Intermediate-risk.

Who this might be right for
Leukemia, Myeloid, Acute
Shaare Zedek Medical Center 20
Large-scale testing (Phase 3)Study completedNCT02870777
What this trial is testing

MRD-directed Therapy for Low-risk and Intermediate-risk AML.

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual Disease
Nanfang Hospital, Southern Medical University 743
Testing effectiveness (Phase 2)WithdrawnNCT05829434
What this trial is testing

Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Neoplasm
Uwe Platzbecker
Large-scale testing (Phase 3)Study completedNCT02461121
What this trial is testing

HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Load More Results